CoChat

Comprehensive, Comparative Evaluation of 35 Manual SARS-CoV-2 Serological Assays

Open access
Dimech, Wayne, Curley, Shannon, Subissi, Lorenzo, Ströher, Ute, Perkins, Mark D., Cunningham, Jane · 2023 · Microbiology Spectrum

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

The markets have been flooded with hundreds of SARS-CoV-2 serology tests, and although there are many published reports on their performance, comparative reports are far fewer and tend to be limited to only a few tests. In this report, we comparatively assessed 35 rapid diagnostic tests or microtiter plate enzyme immunoassays (EIAs) using a large set of samples from individuals with a history of mild to moderate COVID-19, commensurate with the target population for serosurveillance, which included serum samples from individuals previously infected, at undetermined time periods, with other seasonal human coronaviruses, Middle East respiratory syndrome coronavirus (MERS-CoV), and SARS-CoV-1.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/spectrum.05101-22

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 Invalid test rates, concordances with recent infection (n = 199), and specificities (n = 300) of rapid test devices testing for both IgG and IgM. Concordance and specificity results are presented as a heat map, with shades of green representing results of >90%, shades of yellow representing results of between 60 and 90%, and orange representing results of <60%.
FIG 1 Invalid test rates, concordances with recent infection (n = 199), and specificities (n = 300) of rapid test devices testing for both IgG and IgM. Concordance and specificity results are presented as a heat map, with shades of green representing results of >90%, shades of yellow representing results of between 60 and 90%, and orange representing results of <60%.CC BY · PubMed Central
FIG 2 Invalid test rates, concordances with recent infection, and specificities of rapid test devices that report a single result for IgG only, total antibodies, or neutralizing antibodies presented as a heat map, with shades of green representing results of >90%, shades of yellow representing results of between 60 and 90%, and orange representing results of <60%. NA, not assessed; Total, total antibodies; Nt, neutralizing antibodies.
FIG 2 Invalid test rates, concordances with recent infection, and specificities of rapid test devices that report a single result for IgG only, total antibodies, or neutralizing antibodies presented as a heat map, with shades of green representing results of >90%, shades of yellow representing results of between 60 and 90%, and orange representing results of <60%. NA, not assessed; Total, total antibodies; Nt, neutralizing antibodies.CC BY · PubMed Central
FIG 3 Number of reactive results of testing samples from individuals having potentially cross-reacting or interfering substances or known past infection with SARS-CoV-1, MERS-CoV, and seasonal human coronavirus (HCoV-229E, HCoV-NL63, or HCoV-OC43). A heat map presents test kit results, with those having fewer than 10 false-reactive results for each population highlighted in shades of green. Those with between 10 and 30 false-reactive results are highlighted in shades of yellow, and those with >30 false-reactive results are highlighted in orange. NA, not applicable. *Includes samples from individuals having past MERS-CoV and seasonal coronavirus infections and excludes SARS-CoV-1 samples.
FIG 3 Number of reactive results of testing samples from individuals having potentially cross-reacting or interfering substances or known past infection with SARS-CoV-1, MERS-CoV, and seasonal human coronavirus (HCoV-229E, HCoV-NL63, or HCoV-OC43). A heat map presents test kit results, with those having fewer than 10 false-reactive results for each population highlighted in shades of green. Those with between 10 and 30 false-reactive results are highlighted in shades of yellow, and those with >30 false-reactive results are highlighted in orange. NA, not applicable. *Includes samples from individuals having past MERS-CoV and seasonal coronavirus infections and excludes SARS-CoV-1 samples.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 4

  1. World Health Organization. 2020. Advice on the use of point-of-care immunodiagnostic tests for COVID-19. World Health Organization, Geneva, Switzerland.
  2. Foundation for New and Innovative Diagnostics. 2020. FIND evaluation of SARS-COV-2 antibody (AB) detection tests. Foundation for New and Innovative Diagnostics, Geneva, Switzerland. https://www.finddx.org/covid-19/find-evaluations-of-sars-cov-2-assays/find-evaluations-of-sars-cov-2-ab-tests/. Accessed 29 April 2023.
  3. World Health Organization. 2020. Target product profiles for priority diagnostics to support response to the COVID-19 pandemic v.1.0. World Health Organization, Geneva, Switzerland.
  4. World Health Organization Emergencies Preparedness. 2020. Population-based age-stratified seroepidemiological investigation protocol for coronavirus 2019 (COVID-19) infection (version 2). World Health Organization, Geneva, Switzerland.

Cited by

See all 4

Metadata

Authors
Dimech, W., Curley, S., Subissi, L., Ströher, U., Perkins, M. D., & Cunningham, J.
Affiliations
  • National Serology Reference Laboratory, Fitzroy, Australia
  • World Health Organization (CH)
Corresponding author
Dimech, Wayne
Venue
Microbiology Spectrum
Published
2023-06-15
Volume
11
Issue
3
Pages
e0510122-e0510122
ISSN
2165-0497 (ISSN-L)
OpenAlex
W4375954725
Cited by
4
References
17
Citations by year
2026: 1 · 2024: 2 · 2023: 1
FWCI
0.83
Type
journal article
Language
en
Open access
Licence
Locations
  • Microbiology Spectrum (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
World Health Organization (2022/1041859-0)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
SARS-CoV-2, rapid diagnostic tests, enzyme immunoassay, serological surveillance, diagnostic accuracy, seasonal human coronaviruses, MERS-CoV, SARS-CoV-1
MeSH terms
COVID-19, SARS-CoV-2, COVID-19 Testing, Antibodies, Viral, Humans, Clinical Laboratory Techniques, Middle East Respiratory Syndrome Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.